Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halothane hepatitis.

L Ranek

    Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Halothane hepatitis, a liver injury, typically occurs after repeated anesthetic exposures. Avoiding re-exposure is key to preventing this rare but serious condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Intrahepatic cholestasis of pregnancy. New treatment].

    Ugeskrift for laeger·1999
    Same author

    Pharmacokinetics of troglitazone, a PPAR-gamma agonist, in patients with hepatic insufficiency.

    European journal of clinical pharmacology·1998
    Same author

    Pitfalls in intracranial pressure monitoring in fulminant hepatic failure.

    Journal of hepatology·1997
    Same author

    Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices.

    Scandinavian journal of gastroenterology·1995
    Same author

    The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis.

    Chemical research in toxicology·1995
    Same author

    [Fulminant liver failure before and after introduction of liver transplantation at Rikshospitalet].

    Ugeskrift for laeger·1995
    Same journal

    Diversification in toxicology--man and environment. Proceedings of the 1997 EUROTOX Congress. Arhus, Denmark, June 25-28, 1997.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Comparison of GST theta activity in liver and kidney of four species.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Extrahepatic cytochrome P450: role in in situ toxicity and cell-specific hormone sensitivity.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    The use of transgenic animals to assess the role of metabolism in target organ toxicity.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    Same journal

    Population responses to contaminant exposure in marine animals: influences of genetic diversity measured as allozyme polymorphism.

    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement·1998
    See all related articles

    Area of Science:

    • Anesthesiology
    • Hepatology
    • Toxicology

    Background:

    • Halothane (2-bromo-2-chloro-1:1:1-trifluoroethane) is a widely used volatile anesthetic.
    • Halothane hepatitis is a recognized clinical entity, though its pathogenesis remains unclear.
    • This liver injury is associated with repeated halothane exposures within a short period.

    Purpose of the Study:

    • To summarize the current understanding of halothane hepatitis.
    • To highlight the clinical characteristics and incidence of halothane-induced liver injury.
    • To provide recommendations for the prevention of halothane hepatitis.

    Main Methods:

    • Literature review on halothane hepatitis.
    • Analysis of reported cases and clinical observations.

    Related Experiment Videos

  • Epidemiological estimation of incidence and lethality.

    • Main Results:

    • Halothane hepatitis incidence is estimated at 1 in 8000 anesthesias.
    • Lethality is estimated at 1 in 40000 anesthesias.
    • Clinical presentation is linked to multiple halothane exposures.

    Conclusions:

    • Halothane hepatitis is an accepted clinical entity.
    • Prevention strategies include avoiding repeated halothane anesthesia and re-exposure after unexplained liver damage.
    • Further research into the pathogenesis of halothane-induced liver injury is warranted.